News Image

ORICĀ® Pharmaceuticals Announces Presentation at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Oct. 09, 2024 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that the company will present a poster at the EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics to be held October 23-25, 2024, in Barcelona, Spain.

Read more at globenewswire.com

ORIC PHARMACEUTICALS INC

NASDAQ:ORIC (2/11/2025, 8:00:01 PM)

After market: 9.9 +0.05 (+0.51%)

9.85

-1.38 (-12.29%)

ORIC Latest News and Analysis

ChartMill News Image15 hours ago - ChartmillTuesday's session: gap up and gap down stocks

Let's have a look at the gap up and gap down stocks in today's session.

Follow ChartMill for more